Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. D. (Dicky) Struik

Publicaties

Assessing Nutraceuticals for Hepatic Steatosis: A Standardized In Vitro Approach

FGF1 ameliorates hepatic steatosis through acute activation of the unfolded protein response and VLDL production

Loss of Early Growth Response Protein 1 in the Liver Leads to Hepatic Lipid Accumulation Driven by an Imbalance Between Fatty Acid β-Oxidation and Oxidative Phosphorylation

Loss of Early Growth Response Protein 1 in the Liver Leads to Hepatic Lipid Accumulation Driven by an Imbalance Between Fatty Acid β-Oxidation and Oxidative Phosphorylation

VPS35 controls hepatocellular proliferation through SRC signalling and promotes diethyl nitrosamine-induced tumor initiation

Beta-Klotho Protein Expression in Healthy Human Tissues and Liver Biopsies From Patients With MASLD or MASH

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho

Pharmacological inhibition of MEK1/2 signaling disrupts bile acid metabolism through loss of Shp and enhanced Cyp7a1 expression

A novel role for GalNAc-T2 dependent glycosylation in energy homeostasis

Autocrine FGF1 signaling promotes glucose uptake in adipocytes